Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

ITCH × Prednisone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 240 Lymphoma 178 Lymphoma, Large B-Cell, Diffuse 172 Precursor Cell Lymphoblastic Leukemia-Lymphoma 87 Lymphoma, Follicular 78 Lymphoma, Non-Hodgkin 73 Burkitt Lymphoma 66 Multiple Myeloma 64 Leukemia 57 Hodgkin Disease 45 Lymphoma, Mantle-Cell 41 Neoplasms 34 Lymphoma, T-Cell, Peripheral 31 Lymphoma, B-Cell 30 Lymphoma, B-Cell, Marginal Zone 27 Lymphoma, Large-Cell, Anaplastic 26 Neoplasm Metastasis 25 Lymphoma, Large-Cell, Immunoblastic 24 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 22 Leukemia, Lymphocytic, Chronic, B-Cell 22 Neoplasms, Plasma Cell 21 Recurrence 20 Immunoblastic Lymphadenopathy 15 Dendritic Cell Sarcoma, Interdigitating 15 Lymphoma, T-Cell 14 Leukemia, Biphenotypic, Acute 10 Waldenstrom Macroglobulinemia 9 Blast Crisis 9 Primary Myelofibrosis 8 Myelodysplastic Syndromes 8

Interventions

fexofenadine 1 Prednisone 1 Aprepitant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01683552 2012-09-12

AprepIt

Campus Bio-Medico University

Phase 2 Completed

ITCH

Data powered by HemOnc (CC BY 4.0) Colophon ⚡